ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 102627 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 102627; 2) Community: the network communities that were significantly associated with the response to NSC 102627; 3) Molecule: the relationships between components within communities and NSC 102627; 4) MDR: the compounds that were significantly associated with the NSC 102627.

NSC Compound Enrichment Correlation
NSC 106557 5.alpha.,25D-Spirostan-3.beta.-ol glycoside 0.0352028253287042 0.40598535
NSC 11232 Anisole-2-azo-.beta.-naphthol 0.0352028253287042 0.095336228
NSC 11240 Aizen Victoria Blue BOH 0.0352028253287042 -0.052101211
NSC 132230 Null 0.0352028253287042 0.22265549
NSC 1797 o-Aato-amidoazotoluol(German) 0.0352028253287042 0.56333778
NSC 187546 Ethanimidamide, 2-chloro-N-(tricyclo[3.3.1.1(3,7)]dec-1-ylmethyl)-, monohydrochloride 0.0352028253287042 0.47605924
NSC 2039 Bioquin 0.0352028253287042 0.3388449
NSC 266046 Oxaliplatin 0.0352028253287042 0.4614649
NSC 329515 Kijanimicin sodium salt 0.0352028253287042 0.46725708
NSC 36525 8-[(4-tert-butylphenoxy)methyl]-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione 0.0352028253287042 0.18044306
Total:122  Current:87    [First] [Prev] [Next] [Last]